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Abstract 
Background: Basal cell carcinoma 
(BCC) is the commonest skin malignancy 
with a significant risk of recurrence and new 
primaries.  The major risk factor is 
ultraviolet (UV) radiation, which is relevant 
to Malta, where the UV index is frequently 
high. 
Objective: The aim of this study was to 
follow up patients diagnosed with BCC, 
analyse the occurrence of subsequent 
malignant and pre-malignant skin tumours 
and assess whether variables like age and 
gender modify risk. This will aid local 
screening methods and follow-up protocols. 
Method: Patients registered with BCC 
in the Malta National Cancer Registry in 
2007 were included in our study. Histology 
results belonging to these patients were 
followed up until the end of 2014. Risk of 
developing further lesions when accounting 
for age and gender was calculated using the 
Chi^2 test for Independence and hazard 
ratios. 
Results: A total of 382 patients were 
diagnosed with BCC in 2007. Almost one 
third of these patients (30.1%) had at least 
another skin tumour biopsied thereafter; 
71.7% of these tumours were BCCs. 
Squamous cell carcinomas and actinic 
keratoses were also commonly biopsied. 
Nine patients developed  malignant 
melanoma.  The commonest location for 
BCCs and other non-melanoma skin 
tumours was the face. Males and the elderly 
had significantly higher risks to develop 
further skin tumours, as reflected by our 
statistical data. 
Conclusion: Our results are consistent 
with international data. BCC fulfils most 
criteria for screening, thus follow-up in high 
risk patients is recommended. 
Keywords 
Carcinoma, Basal Cell; Follow-up 
studies; Malta; Risk factors; Skin neoplasms 
Introduction 
Basal cell carcinoma (BCC) is the 
commonest skin malignancy, and incidence 
rates are increasing. Individuals with a 
history of BCC have increased risk of 
developing new lesions especially in high-
risk regions like the face. Although rarely 
metastatic and overall slow-growing, BCC 
may cause aesthetic and possibly functional 
complications from extensive local tissue 
destruction. The major risk factor for the 
development of BCC is exposure to 
ultraviolet radiation.1 This has important 
implications for the Maltese Islands, where 
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the UV indices can go up to very high levels 
during the spring and summer seasons.2 
The purpose of this project was to 
obtain a local perspective on the frequency 
of new malignant and pre-malignant skin 
lesions in patients with past BCC and assess 
whether variables such as age and gender 
modify risk.  This information will provide 
more knowledge to aid follow-up protocols 
and screening methods for patients with 
BCC. 
 
Method 
This was a retrospective study, using 
data from the Malta National Cancer 
Registry (MNCR) at the Department of 
Health Information and Research, with the 
approval of the Data Protection Unit.  The 
MNCR indexes every histopathological 
confirmation of cutaneous BCC on a yearly 
basis, gathering reports from all laboratories 
across the Maltese Islands, most of which 
come from the Pathology Department of the 
main general hospital, Mater Dei. 
In this study, we included all those 
patients recorded in the MNCR to have BCC 
in the year 2007.  Data extracted from this 
list included age at time of diagnosis, 
gender, date of death for deceased patients, 
as well as the site and morphology of the 
BCC.  This data did not include information 
about completeness of margins of excision. 
In order to assess whether this cohort of 
patients developed other skin tumours after 
2007, a search for the relevant 
histopathology reports was performed on 
iSoft Clinical Manager (iCM), the local 
electronic database that records patients’ 
investigations.  All histopathology results 
showing skin tumours (pre-malignant and 
malignant) were included up to the end of 
2014.  From these reports we gathered the 
following data: the number of cutaneous 
malignant and pre-malignant lesions 
confirmed by histology per individual, the 
site and morphology of these lesions, and 
the completeness of the margin of excision. 
All data was organised in a spreadsheet 
and analysed with the software Stata® 11.2 
(StataCorp LLC, Texas). For all statistical 
analyses, confidence levels of 95% were 
applied and p-values of less than 0.05 were 
taken to be statistically significant.   
The Pearson’s Chi-Square Test for 
Independence was used to assess for a 
relationship between gender and the 
likelihood to have further skin tumours. The 
Kaplan-Meier survival estimate was used to 
measure the time between the initial BCC 
and development of the first skin malignant 
or pre-malignant lesion biopsied thereafter, 
looking for a significant difference between 
males and females. Hazard ratios (HR) for 
gender and age in relation to the amount of 
time passed to the second skin tumour were 
calculated using a Cox Regression analysis, 
adjusting for ties with the Breslow Method. 
A ratio more than one was taken to imply 
increased risk. 
For the deceased patients, the Chi-
Square test for Goodness of Fit was used to 
analyse the difference between the observed 
and expected number of deaths, correcting 
for gender. Data was entered into a 
contingency table, placing male and female 
variables in rows, and alive and deceased 
variables in columns.  The expected values 
of deceased patients for each gender were 
calculated by multiplying the row total with 
the column total, and dividing that against 
the total number of patients. In this analysis 
one patient had to be omitted as the date of 
death was also the date of incidence.   
 
Results 
Demographic analysis  
A total of 382 patients were diagnosed 
with BCC in 2007; no patient was found to 
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have more than one BCC biopsied in that 
year.  The age ranged from 16-93 years at 
the time of diagnosis.  The mean age of 
presentation was 66.2 years (see Figure 1).  
Out of the 382 patients, 115 (30.1%) had 
further skin tumours biopsied on follow-up, 
whilst 267 patients (69.9%) had no further 
biopsies documented. Those patients who 
developed subsequent skin tumours had a 
slightly older mean age (69.2 years) when 
compared to the general study population. In 
this study, four patients were younger than 
30 years at initial presentation. They had no 
further documented biopsies in the follow-
up period; three of these four patients were 
female. 
The majority of patients presenting 
with a BCC in 2007 were male (n=227, 
59.4%).  When the Chi-Square Test for 
Independence was used to assess for a 
relationship between gender and the 
likelihood to have further tumours, a Chi^2 
value of 11.093 and p-value of <0.001 were 
obtained, implying that males were 
significantly more likely to have further skin 
tumours.  
The Kaplan-Meier estimation (Figure 
2) shows marked separation between the 
female and male groups; thus, the time to 
develop a second skin tumour after the first 
BCC is significantly shorter for males.  
When the Cox regression model was applied 
to assess the effects of gender and age on the 
time to develop a second skin tumour, the 
following values were obtained: HR of 1.84 
and p-value of 0.004 for male gender, and a 
HR of 1.02 and p-value of 0.016 for age.  
These hazard ratios suggest that the two 
variables have a causative effect on the time 
to second tumour, especially male gender. 
 
Figure 1: Distribution curve of the age of the patients presenting with BCC in 2007 
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Figure 2: Kaplan-Meier Estimation for time between first BCC in 2007 until first skin tumour 
biopsied thereafter according to gender 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        At the time of the study, 18.6% of the 
382 patients were deceased (n=71). When 
the Chi-Square test for Goodness of Fit was 
applied, a Chi ^2 value of 2.486 was 
obtained, with a p-value of 0.115.  This 
implies no statistical difference in the 
number of deaths when correcting for 
gender. 
 
Analysis of the skin tumours biopsied after 
2007 
In those 115 patients with further skin 
tumours, a total of 460 skin tumours were 
biopsied and sent for histopathology during 
the follow-up period (refer to Table 1).  
Whilst the majority of these were BCCs 
(n=330, 71.7%), there was a mixture of 
other skin lesions, namely squamous cell 
carcinomas (SCCs), cutaneous malignant 
melanomas, actinic keratoses (AKs), 
keratoacanthomas and one Merkel cell 
carcinoma. Ten melanomas were excised 
from nine patients in this cohort.  
All the tumours included in this study 
were analysed according to site (refer to 
Table 2). Of the BCCs excised in 2007, 
66.8% were located on the head and neck. 
The next most common location was the 
trunk (11.3%). Of the BCCs excised after 
2007, 20.3% were located on the trunk, 
46.3% (n=31) of which were of the 
superficial type. From the BCCs sent for 
histology in 2007, 10.2% (n=39) were listed 
under the topographical code C44.9, 
meaning that the location of the biopsy was 
undocumented. In view of poor 
documentation, it was often difficult to 
recognise which BCCs after 2007 were 
recurrences at the same site as opposed to 
new primaries. Regarding the site of the 
cutaneous malignant melanomas, four of the 
ten melanomas in our study were located in 
the head and neck region (one on the face 
and three on the scalp/neck); the remaining 
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six melanomas were distributed evenly on 
the trunk and lower limbs. 
The number of malignant and pre-
malignant skin tumours biopsied for each 
individual after 2007 is presented in Figure 
3. Ten patients had more than ten skin
tumours removed after 2007 (Table 3). One
patient had 22 skin tumours removed in this
seven-year period. No melanomas were
biopsied in this group of patients. The
medical records of these patients were
reviewed for documentation of any risk
factors explaining their high incidence of
skin tumours.  Documentation occurred in
only two cases, both of which were noted to
have a history of chronic sun exposure.
Notably, there was only one female in this
group of patients; she had a documented
history of breast cancer and Sjogren’s
syndrome in addition to a history of
sunbathing.
Our final analysis concerns the 
completeness of the margin of excision for 
the skin tumours biopsied after 2007 (refer 
to Table 4).  Punch biopsy reports were only 
taken into consideration if the lesion was not 
subsequently excised.  The percentage of 
BCCs reported to be incompletely excised 
and not followed by a subsequent wider 
excision was 8.8%.  
Discussion 
In our study we confirmed that the 
majority of patients presenting with BCC in 
2007 were males older than 60.  This is 
similar to trends in international data, 
although it is well-known that rates in 
females are on the rise in view of altered 
sun-seeking behaviour.3 Some studies show 
that in younger patients the incidence of 
BCC is higher in females.4 Although the 
number of patients younger than 30 years in 
our original study cohort was too small to 
draw accurate conclusions as there were 
only four, our findings seem to support this 
as three were female. 
Table 1: The number of malignant and pre-malignant skin tumours biopsied between 2008 and 
2014, according to histology 
Histology Number of skin tumours 
Basal cell carcinomas 330 (71.7%) 
(of which 47 were superficial BCCs) 
Squamous cell carcinomas 57 (12.4%) 
Actinic keratoses 57 (12.4%) 
Malignant melanomas 10 (2.2%) 
Keratoacanthomas 5 (1.1%) 
Merkel cell carcinoma 1 (0.2%) 
TOTAL 460 
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Table 2: Sites of basal cell carcinomas biopsied in 2007 and of the skin tumours biopsied 
thereafter.  Codes used are from ICD-O-3 
 
Figure 3: Histogram showing the number of malignant and pre-malignant skin lesions biopsied 
between 2008 and 2014 and the frequency of patients per number 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Topography Code and 
Anatomical Site 
BCC in 2007 BCCs between  
2008 and 2014 
Other malignant and pre-malignant 
skin tumours between  
2008 and 2014 
TOTAL No. of tumours 382  330  130  
C44.0 Lip 12 (3.1%) 6 (1.8%) 4 (3.1%) 
C44.1 Eyelid 24 (6.3%) 8 (2.4%) 0 
C44.2 External ear 20 (5.2%) 10 (3.0%) 9 (6.9%) 
C44.3 
 
Face 
 (Nose) 
183 (47.9%) 
- 
166 (50.3%) 
(47) 
49 (37.7%) 
(8) 
C44.4 Scalp, neck 16 (4.2%) 18 (5.5%) 24 (18.5%) 
C44.5 
 
Trunk 
 
43 (11.3%) 
 
67 (20.3%) 
(31 of superficial 
type) 
14 (10.8%) 
 
C44.6 Upper limb 24 (6.3%) 20 (6.1%) 14 (10.8%) 
C44.7 Lower limb 15 (3.9%) 28 (8.5%) 15 (11.5%) 
C44.8 Overlapping  6 (1.6%) 0 0 
C44.9 Skin, Not 
specified 
39 (10.2%) 7 (2.1%) 1 (0.8%) 
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Table 3: Patients who had 10 or more tumours biopsied between 2008 and 2014 after the 
presenting BCC in 2007 
 
 
 
Table 4: Completeness of margin of excision for BCCs and other skin tumours biopsied 
between 2008 and 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient  Gender 
Age 
in 2007 
Site of 
BCC  
in 2007 
No. of 
subsequent 
BCCs  
(2008-2014) 
No. of subsequent 
other skin 
tumours   
(2008-2014) 
Documented risk 
factors 
1 M 77 Face 4 
2 SCC 
4 AK 
Not documented 
2 M 76 Face 9 4 AK 
Deceased - records 
unavailable 
3 M 62 Face 4 
8 SCC 
1 AK 
Not documented 
4 F 62 
Not 
specified 
 
8 
 
2 AK 
History of sunbathing; 
Breast Ca; Sjogren’s 
syndrome 
5 M 82 Face 11 
2 SCC 
3 AK 
Not documented 
6 M 69 
Not 
specified 
 
5 
 
2 SCC 
8 AK 
1 KA 
Records unavailable 
7 M 76 Face 13 4 AK Records unavailable 
8 M 61 Face 10 
2 SCC 
5 AK 
Not documented 
9 M 77 Trunk 20 nil 
Deceased – records 
unavailable 
10 M 75 Face 18 
1 SCC 
3 AK 
Outdoor occupation 
documented 
Margin of excision Basal cell carcinomas Other skin tumours TOTAL 
Complete 292 (88.5%) 85 (65.4%) 
(includes all 10 melanomas) 
377 (82.0%) 
Incomplete 29 (8.8%) 30 (23.1%) 59 (12.8%) 
Unspecified or uncertain 9 (2.7%) 11 (8.5%) 20 (4.3%) 
Punch biopsies 0 4 (3.1%) 4 (0.9%) 
TOTAL 330 130 460 
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We have also found that 30.1% of the 
382 patients diagnosed with BCC in 2007 
had at least another skin tumour biopsied in 
the subsequent seven-year period; 71.7% of 
these were BCCs. This is consistent with 
other studies, demonstrating that a history of 
BCC increases the risk for new BCCs.5-6 It 
was interesting to note that SCCs and AKs 
were regularly associated with BCCs, while 
only nine patients developed cutaneous 
malignant melanoma. Cutaneous SCCs tend 
to develop following chronic sun exposure, 
whilst melanomas are typically associated 
with sunburns in childhood and adolescence. 
The risk of BCC seems to depend on the 
ability of the skin to tan. Good tanners tend 
to develop BCC after chronic sun exposure, 
while poor tanners are at increased risk of 
BCC with chronic sun exposure as well as 
with intermittent sunburning.7-8 
Immunosuppression increases the risk to 
develop multiple skin cancers of all types 
(particularly SCCs) and worsens prognosis.9 
As expected with a tumour that rarely 
metastasizes, the presence of a BCC did not 
contribute significantly to mortality when 
correcting for age and gender. 
Not only did males outnumber females 
in our original study population, but males 
were also more likely than females to 
develop subsequent skin cancers. This was 
especially highlighted in the ten patients 
who had more than ten subsequent skin 
tumours – nine were male.  The most 
probable explanation is that males are 
exposed to heavier sun exposure from 
occupational and recreational activities. In 
our study, males also showed a shorter time 
interval than females to develop the next 
skin tumour. 
The commonest site for BCCs was the 
head and neck region, as has been observed 
internationally.1,3 However, 20.3% of BCCs 
occurring after 2007, as opposed to 11.3% in 
2007, were located on the trunk. With 
regards to the ten recorded melanomas, six 
were located on the trunk or lower limbs.  
This emphasises the importance of not 
limiting examination to the head and neck 
when following up patients with BCCs, as 
skin tumours located on other parts of the 
body might be missed.  
Our last observation is that the local 
percentage of incompletely excised BCCs 
was 8.8%. International rates cited vary 
from 4-16.6%,10 however these statistics 
take into account the more accurate 
technique of Mohs microscopic surgery, 
which is unavailable in Malta. For SCCs and 
especially AKs, the rate of incomplete 
excision was higher, but these are usually 
clinically less well-delineated than BCCs. 
Of note is that all melanomas were 
completely excised.  In clinical practice, 
when a BCC is reported to be incompletely 
excised, sometimes it is decided to follow 
up the patient for recurrence rather than 
perform a wider surgical excision.  The 
decision in these situations would be taken 
on an individual basis, depending on the 
histology of the tumour, the location, any 
associated immunosuppression and patient 
preference.  We have no data on how many 
of the tumours biopsied that were reported 
to be incompletely excised subsequently 
underwent treatment with cryotherapy, 
topical 5-fluorouracil, imiquimod cream, or 
radiotherapy. 
This study has a number of limitations, 
such as the fact that it was done 
retrospectively based on available iCM data 
and relying on the number of skin tumours 
biopsied and sent for histology – in this 
study no patients were examined clinically. 
The prevalence and frequency of skin 
tumours between 2008 and 2014 reported 
here are likely to be an under-representation. 
Patients having further lesions excised and 
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sent for histological analysis to private 
laboratories would not be available through 
iCM and therefore would not be included in 
this study. Patients might have developed 
further skin tumours which were 
misdiagnosed, or did not seek medical 
opinion. Finally, further skin tumours 
(including recurrences) might have been 
diagnosed by dermatologists, and treated 
with cryotherapy, 5-fluorouracil or 
imiquimod cream, without biopsy. This 
happens occasionally with very superficial 
non-melanocytic tumours like superficial 
BCC or Bowen’s disease of the skin. Actinic 
keratoses are also not routinely biopsied 
before treatment with cryotherapy, 5-
fluorouracil or imiquimod cream, but are 
typically biopsied when hypertrophic or 
resistant to treatment to rule out invasive 
disease.   
A systematic review published in 2016 
dwells on whether screening for early 
detection of BCC is worthwhile.11 It 
concludes that BCC fulfils most of the 
WHO criteria for screening. Early diagnosis 
whilst BCCs are relatively small allows for 
less aggressive treatment options. This 
would be particularly relevant in the facial 
region, where the costs and morbidity 
associated with the removal of large, 
disfiguring and complex lesions may be 
significant. Naked-eye inspection and 
dermoscopy are all that would be needed for 
early detection, making screening 
potentially cost-effective.  
Mass screening of the entire population 
is impractical.  However, we propose that 
patients who are diagnosed with BCC and 
are at high risk of developing further 
tumours are offered regular follow-up. This 
would include immunosuppressed patients 
and those with more than one BCC at first 
diagnosis.5 The incidence of subsequent 
BCC increases rapidly with the number of 
previous BCCs, so patients with a history of 
multiple BCCs would also benefit from 
regular and long-term follow-up.6 Patient 
education is also paramount. Patients should 
be made aware of the significant rate of 
subsequent skin cancers and what they may 
look like, so that they may be vigilant and 
present early with any suspicious lesions 
that may develop. 
Conclusion 
In conclusion, our study shows that 
almost one third of patients diagnosed with a 
BCC in Malta developed subsequent skin 
tumours within a seven-year follow-up 
period. This risk is higher in males, the 
elderly and those who have had a previous 
BCC.  Regular follow-up is recommended 
for such patients as well as for 
immunosuppressed patients.   
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